Announced Tue, 11 Aug, 2026 · 17:13 IST
Board approves Q1 FY27 results, re-appoints MD for 3 years
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction
Awaiting price reaction for this filing.
AI summary
Board approved unaudited Q1 FY27 results (quarter ended June 30, 2026), reviewed by statutory auditors with no issues flagged. EPS stood at 0.26 versus 0.15 in Q1 FY26. Board re-appointed Mr. Dipen Maheshwari as Managing Director for 3 years effective April 1, 2027, pending shareholder approval at the 32nd AGM on September 17, 2026.
Likely market impact
Routine re-appointment of existing MD signals management continuity. No leadership change. Results reviewed cleanly by auditors.